Biotherapeutics Cell Line Development Market 2027 by Process, Option and Geography | The Insight Partners

Biotherapeutics Cell Line Development Market to 2027 - Global Analysis and Forecasts by Process (Transfection and Selection, Single cell cloning); Option (In-house, Outsource, Hybrid) and Geography

Report Code: TIPRE00007166 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Biotherapeutic drug therapy products consist of the active substance that is extracted or produced from a biological source. Biotherapeutic products are derived from recombinant DNA technology such as interferons, interleukins, and growth factors. Have significantly presented a major advance in the safety and effectiveness of therapeutic peptides and proteins. Biotherapeutic products have a strong record in treating many life-threatening and chronic diseases.

MARKET DYNAMICS

The biotherapeutics cell line development market is anticipated to grow in the forecast, owing to growth in demand for biotherapeutics together with imminent launch of several biopharmaceutical drugs. In addition, increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, cancer are expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Biotherapeutics Cell Line Development Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of biotherapeutics cell line development market with detailed market segmentation by process, option and geography. The biotherapeutics cell line development market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading biotherapeutics cell line development market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The biotherapeutics cell line development market is segmented on the basis of by process and option. Based on process the market is segmented as transfection & selection, Single cell cloning. The biotherapeutics cell line development market is categorized based on option such as in-house, outsource and hybrid.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biotherapeutics cell line development market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biotherapeutics cell line development market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting biotherapeutics cell line development market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biotherapeutics cell line development market in these regions.

MARKET PLAYERS

The report covers key developments in the biotherapeutics cell line development market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biotherapeutics cell line development market are anticipated to have lucrative growth opportunities in the future with the rising demand for biotherapeutics cell line development market in the global market. Below mentioned is the list of few companies engaged in the Platelet-rich Plasma market.

The report also includes the profiles of key biotherapeutics cell line development market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Beckman Coulter, Inc.
  •  Boehringer Ingelheim International GmbH.
  •  Catalent, Inc
  •  AGC Biologics.
  •  Lonza
  •  Partec (Sysmex Corporation)
  •  Selexis SA
  •  iProgen Biotech
  •  Celltrion Healthcare Co.,Ltd.
  •  Merck KGaA

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biotherapeutics Cell Line Development Market - By Process
1.3.2 Biotherapeutics Cell Line Development Market - By Option
1.3.3 Biotherapeutics Cell Line Development Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOTHERAPEUTICS CELL LINE DEVELOPMENT - GLOBAL MARKET OVERVIEW
6.2. BIOTHERAPEUTICS CELL LINE DEVELOPMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET - REVENUE AND FORECASTS TO 2027 - PROCESS
7.1. OVERVIEW
7.2. PROCESS MARKET FORECASTS AND ANALYSIS
7.3. TRANSFECTION AND SELECTION
7.3.1. Overview
7.3.2. Transfection and Selection Market Forecast and Analysis
7.4. SINGLE CELL CLONING
7.4.1. Overview
7.4.2. Single cell cloning Market Forecast and Analysis
8. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET - REVENUE AND FORECASTS TO 2027 - OPTION
8.1. OVERVIEW
8.2. OPTION MARKET FORECASTS AND ANALYSIS
8.3. IN-HOUSE
8.3.1. Overview
8.3.2. In-house Market Forecast and Analysis
8.4. OUTSOURCE
8.4.1. Overview
8.4.2. Outsource Market Forecast and Analysis
8.5. HYBRID
8.5.1. Overview
8.5.2. Hybrid Market Forecast and Analysis

9. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Biotherapeutics Cell Line Development Market Overview
9.1.2 North America Biotherapeutics Cell Line Development Market Forecasts and Analysis
9.1.3 North America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Process
9.1.4 North America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Option
9.1.5 North America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Countries
9.1.5.1 United States Biotherapeutics Cell Line Development Market
9.1.5.1.1 United States Biotherapeutics Cell Line Development Market by Process
9.1.5.1.2 United States Biotherapeutics Cell Line Development Market by Option
9.1.5.2 Canada Biotherapeutics Cell Line Development Market
9.1.5.2.1 Canada Biotherapeutics Cell Line Development Market by Process
9.1.5.2.2 Canada Biotherapeutics Cell Line Development Market by Option
9.1.5.3 Mexico Biotherapeutics Cell Line Development Market
9.1.5.3.1 Mexico Biotherapeutics Cell Line Development Market by Process
9.1.5.3.2 Mexico Biotherapeutics Cell Line Development Market by Option
9.2. EUROPE
9.2.1 Europe Biotherapeutics Cell Line Development Market Overview
9.2.2 Europe Biotherapeutics Cell Line Development Market Forecasts and Analysis
9.2.3 Europe Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Process
9.2.4 Europe Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Option
9.2.5 Europe Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Biotherapeutics Cell Line Development Market
9.2.5.1.1 Germany Biotherapeutics Cell Line Development Market by Process
9.2.5.1.2 Germany Biotherapeutics Cell Line Development Market by Option
9.2.5.2 France Biotherapeutics Cell Line Development Market
9.2.5.2.1 France Biotherapeutics Cell Line Development Market by Process
9.2.5.2.2 France Biotherapeutics Cell Line Development Market by Option
9.2.5.3 Italy Biotherapeutics Cell Line Development Market
9.2.5.3.1 Italy Biotherapeutics Cell Line Development Market by Process
9.2.5.3.2 Italy Biotherapeutics Cell Line Development Market by Option
9.2.5.4 Spain Biotherapeutics Cell Line Development Market
9.2.5.4.1 Spain Biotherapeutics Cell Line Development Market by Process
9.2.5.4.2 Spain Biotherapeutics Cell Line Development Market by Option
9.2.5.5 United Kingdom Biotherapeutics Cell Line Development Market
9.2.5.5.1 United Kingdom Biotherapeutics Cell Line Development Market by Process
9.2.5.5.2 United Kingdom Biotherapeutics Cell Line Development Market by Option
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Biotherapeutics Cell Line Development Market Overview
9.3.2 Asia-Pacific Biotherapeutics Cell Line Development Market Forecasts and Analysis
9.3.3 Asia-Pacific Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Process
9.3.4 Asia-Pacific Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Option
9.3.5 Asia-Pacific Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Biotherapeutics Cell Line Development Market
9.3.5.1.1 Australia Biotherapeutics Cell Line Development Market by Process
9.3.5.1.2 Australia Biotherapeutics Cell Line Development Market by Option
9.3.5.2 China Biotherapeutics Cell Line Development Market
9.3.5.2.1 China Biotherapeutics Cell Line Development Market by Process
9.3.5.2.2 China Biotherapeutics Cell Line Development Market by Option
9.3.5.3 India Biotherapeutics Cell Line Development Market
9.3.5.3.1 India Biotherapeutics Cell Line Development Market by Process
9.3.5.3.2 India Biotherapeutics Cell Line Development Market by Option
9.3.5.4 Japan Biotherapeutics Cell Line Development Market
9.3.5.4.1 Japan Biotherapeutics Cell Line Development Market by Process
9.3.5.4.2 Japan Biotherapeutics Cell Line Development Market by Option
9.3.5.5 South Korea Biotherapeutics Cell Line Development Market
9.3.5.5.1 South Korea Biotherapeutics Cell Line Development Market by Process
9.3.5.5.2 South Korea Biotherapeutics Cell Line Development Market by Option
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Biotherapeutics Cell Line Development Market Overview
9.4.2 Middle East and Africa Biotherapeutics Cell Line Development Market Forecasts and Analysis
9.4.3 Middle East and Africa Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Process
9.4.4 Middle East and Africa Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Option
9.4.5 Middle East and Africa Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Biotherapeutics Cell Line Development Market
9.4.5.1.1 South Africa Biotherapeutics Cell Line Development Market by Process
9.4.5.1.2 South Africa Biotherapeutics Cell Line Development Market by Option
9.4.5.2 Saudi Arabia Biotherapeutics Cell Line Development Market
9.4.5.2.1 Saudi Arabia Biotherapeutics Cell Line Development Market by Process
9.4.5.2.2 Saudi Arabia Biotherapeutics Cell Line Development Market by Option
9.4.5.3 U.A.E Biotherapeutics Cell Line Development Market
9.4.5.3.1 U.A.E Biotherapeutics Cell Line Development Market by Process
9.4.5.3.2 U.A.E Biotherapeutics Cell Line Development Market by Option
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Biotherapeutics Cell Line Development Market Overview
9.5.2 South and Central America Biotherapeutics Cell Line Development Market Forecasts and Analysis
9.5.3 South and Central America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Process
9.5.4 South and Central America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Option
9.5.5 South and Central America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Biotherapeutics Cell Line Development Market
9.5.5.1.1 Brazil Biotherapeutics Cell Line Development Market by Process
9.5.5.1.2 Brazil Biotherapeutics Cell Line Development Market by Option
9.5.5.2 Argentina Biotherapeutics Cell Line Development Market
9.5.5.2.1 Argentina Biotherapeutics Cell Line Development Market by Process
9.5.5.2.2 Argentina Biotherapeutics Cell Line Development Market by Option

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET, KEY COMPANY PROFILES
11.1. BECKMAN COULTER, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CATALENT, INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. AGC BIOLOGICS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LONZA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PARTEC (SYSMEX CORPORATION)
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SELEXIS SA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. IPROGEN BIOTECH
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. CELLTRION HEALTHCARE CO.,LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MERCK KGAA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1.Beckman Coulter, Inc.
2.Boehringer Ingelheim International GmbH.
3.Catalent, Inc
4.AGC Biologics
5.Lonza
6.Partec (Sysmex Corporation)
7.Selexis SA
8.iProgen Biotech
9.Celltrion Healthcare Co.,Ltd.
10.Merck KGaA